de Godoy L, Rajan A, Banihashemi A, Patel T, Desai A, Bagley S
Brain Sci. 2025; 15(2).
PMID: 40002479
PMC: 11852837.
DOI: 10.3390/brainsci15020146.
Duffau H
Curr Neurol Neurosci Rep. 2025; 25(1):15.
PMID: 39786618
DOI: 10.1007/s11910-024-01402-6.
Li W, Wang Z, Chen S, Zuo M, Xiang Y, Yuan Y
Front Oncol. 2024; 14:1462424.
PMID: 39678512
PMC: 11638224.
DOI: 10.3389/fonc.2024.1462424.
Wang H, Argenziano M, Yoon H, Boyett D, Save A, Petridis P
NPJ Digit Med. 2024; 7(1):292.
PMID: 39427044
PMC: 11490546.
DOI: 10.1038/s41746-024-01277-4.
He W, Huang W, Zhang L, Wu X, Zhang S, Zhang B
MedComm (2020). 2024; 5(9):e722.
PMID: 39252824
PMC: 11381657.
DOI: 10.1002/mco2.722.
Radiogenomic profiling of global DNA methylation associated with molecular phenotypes and immune features in glioma.
Zhuang Z, Lin J, Wan Z, Weng J, Yuan Z, Xie Y
BMC Med. 2024; 22(1):352.
PMID: 39218882
PMC: 11367996.
DOI: 10.1186/s12916-024-03573-y.
Relaxation-Diffusion Spectrum Imaging for Probing Tissue Microarchitecture.
Wu Y, Liu X, Zhang X, Huynh K, Ahmad S, Yap P
Med Image Comput Comput Assist Interv. 2024; 14227:152-162.
PMID: 39184022
PMC: 11340880.
DOI: 10.1007/978-3-031-43993-3_15.
Hybrid Positron Emission Tomography and Magnetic Resonance Imaging Guided Microsurgical Management of Glial Tumors: Case Series and Review of the Literature.
Caglar Y, Buyuktepe M, Sayaci E, Dogan I, Bozkurt M, Peker E
Diagnostics (Basel). 2024; 14(14).
PMID: 39061688
PMC: 11275485.
DOI: 10.3390/diagnostics14141551.
Imaging Role in Diagnosis, Prognosis, and Treatment Response Prediction Associated with High-grade Glioma.
Heidari M, Shokrani P
J Med Signals Sens. 2024; 14:7.
PMID: 38993200
PMC: 11111132.
DOI: 10.4103/jmss.jmss_30_22.
Preoperative prediction of MGMT promoter methylation in glioblastoma based on multiregional and multi-sequence MRI radiomics analysis.
Li L, Xiao F, Wang S, Kuang S, Li Z, Zhong Y
Sci Rep. 2024; 14(1):16031.
PMID: 38992201
PMC: 11239670.
DOI: 10.1038/s41598-024-66653-2.
Amide proton transfer-weighted and arterial spin labeling imaging may improve differentiation between high-grade glioma recurrence and radiation-induced brain injury.
Chen L, Huang L, Zhang J, Li S, Li Y, Tang L
Heliyon. 2024; 10(11):e32699.
PMID: 38961946
PMC: 11219995.
DOI: 10.1016/j.heliyon.2024.e32699.
Rapid detection of IDH mutations in gliomas by intraoperative mass spectrometry.
Hua W, Zhang W, Brown H, Wu J, Fang X, Shahi M
Proc Natl Acad Sci U S A. 2024; 121(23):e2318843121.
PMID: 38805277
PMC: 11161794.
DOI: 10.1073/pnas.2318843121.
Identification of a Single-Dose, Low-Flip-Angle-Based CBV Threshold for Fractional Tumor Burden Mapping in Recurrent Glioblastoma.
Anil A, Stokes A, Karis J, Bell L, Eschbacher J, Jennings K
AJNR Am J Neuroradiol. 2024; 45(10):1545-1551.
PMID: 38782593
PMC: 11448978.
DOI: 10.3174/ajnr.A8357.
Association of body mass index with clinical outcome of primary WHO grade 4 glioma.
Wang J, Hao Z, Li R, Wu W, Huang N, Zhang K
Front Oncol. 2024; 14:1318785.
PMID: 38741777
PMC: 11089228.
DOI: 10.3389/fonc.2024.1318785.
Clinical Theranostics in Recurrent Gliomas: A Review.
Hoggarth A, Muthukumar S, Thomas S, Crowley J, Kiser J, Witcher M
Cancers (Basel). 2024; 16(9).
PMID: 38730666
PMC: 11083317.
DOI: 10.3390/cancers16091715.
THOC6 is a novel biomarker of glioma and a target of anti-glioma drugs: An analysis based on bioinformatics and molecular docking.
Wei C, Gao Y, Li P
Medicine (Baltimore). 2024; 103(19):e37999.
PMID: 38728502
PMC: 11081617.
DOI: 10.1097/MD.0000000000037999.
Transmembrane Protein TMEM230, Regulator of Glial Cell Vascular Mimicry and Endothelial Cell Angiogenesis in High-Grade Heterogeneous Infiltrating Gliomas and Glioblastoma.
Cocola C, Abeni E, Martino V, Piscitelli E, Pelucchi P, Mosca E
Int J Mol Sci. 2024; 25(7).
PMID: 38612777
PMC: 11011566.
DOI: 10.3390/ijms25073967.
Biologically-informed deep neural networks provide quantitative assessment of intratumoral heterogeneity in post-treatment glioblastoma.
Wang H, Argenziano M, Yoon H, Boyett D, Save A, Petridis P
Res Sq. 2024; .
PMID: 38585856
PMC: 10996806.
DOI: 10.21203/rs.3.rs-3891425/v1.
Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm.
Wang L, Wang H, DAngelo F, Curtin L, Sereduk C, Leon G
PLoS One. 2024; 19(4):e0299267.
PMID: 38568950
PMC: 10990246.
DOI: 10.1371/journal.pone.0299267.
Artificial intelligence-based MRI radiomics and radiogenomics in glioma.
Fan H, Luo Y, Gu F, Tian B, Xiong Y, Wu G
Cancer Imaging. 2024; 24(1):36.
PMID: 38486342
PMC: 10938723.
DOI: 10.1186/s40644-024-00682-y.